Bio Blast Pharma (ORPN) - NASDAQ
Company Description
Bio Blast Pharma Ltd. engages in the identification, licensing, acquisition, development, and commercialization of drugs for patients with rare and ultra rare genetic and metabolic diseases. Its product candidates include Protein Stabilizing, Read-through and Mitochondrial Protein Replacement... More
Sector: Healthcare
Industry: Biotechnology
Country: United States